Literature DB >> 15705897

Silencing of CXCR4 blocks breast cancer metastasis.

Zhongxing Liang1, Younghyoun Yoon, John Votaw, Mark M Goodman, Larry Williams, Hyunsuk Shim.   

Abstract

RNA interference technology, silencing targeted genes in mammalian cells, has become a powerful tool for studying gene function. For the first time in cancer research, we show that direct injection of a pool of naked small interfering RNA (siRNA) duplexes can prevent tumorigenesis in an animal model, suggesting a novel preventive and therapeutic strategy for cancer management. As a model system, we used siRNA duplexes of CXCR4 to block breast cancer metastasis. Here, we show that blocking CXCR4 expression at the mRNA level by a combination of two siRNAs impairs invasion of breast cancer cells in Matrigel invasion assay and inhibits breast cancer metastasis in an animal model. Targeting more than one site of the target gene may be important to overcome the functional redundancy of other variants of a single gene, especially in in vivo experiments. Moreover, our studies confirm the necessity of CXCR4 in breast cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15705897      PMCID: PMC3734941     

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

Review 1.  RNA interference--2001.

Authors:  P A Sharp
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

2.  Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate.

Authors:  S M Elbashir; J Martinez; A Patkaniowska; W Lendeckel; T Tuschl
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

3.  RNA silencing: the genome's immune system.

Authors:  Ronald H A Plasterk
Journal:  Science       Date:  2002-05-17       Impact factor: 47.728

4.  Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.

Authors:  Miguel A Martínez; Arantxa Gutiérrez; Mercedes Armand-Ugón; Julià Blanco; Mariona Parera; Jordi Gómez; Bonaventura Clotet; José A Esté
Journal:  AIDS       Date:  2002-12-06       Impact factor: 4.177

5.  Gene silencing by systemic delivery of synthetic siRNAs in adult mice.

Authors:  Dag R Sørensen; Marianne Leirdal; Mouldy Sioud
Journal:  J Mol Biol       Date:  2003-04-04       Impact factor: 5.469

6.  Efficient delivery of siRNA for inhibition of gene expression in postnatal mice.

Authors:  David L Lewis; James E Hagstrom; Aaron G Loomis; Jon A Wolff; Hans Herweijer
Journal:  Nat Genet       Date:  2002-07-29       Impact factor: 38.330

7.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

8.  RNA interference targeting Fas protects mice from fulminant hepatitis.

Authors:  Erwei Song; Sang-Kyung Lee; Jie Wang; Nedim Ince; Nengtai Ouyang; Jun Min; Jisheng Chen; Premlata Shankar; Judy Lieberman
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

9.  Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

Authors:  Sigrid Hatse; Katrien Princen; Gary Bridger; Erik De Clercq; Dominique Schols
Journal:  FEBS Lett       Date:  2002-09-11       Impact factor: 4.124

10.  Analysis of gene function in somatic mammalian cells using small interfering RNAs.

Authors:  Sayda M Elbashir; Jens Harborth; Klaus Weber; Thomas Tuschl
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

View more
  159 in total

1.  Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide.

Authors:  Xi Wang; Ping Gao; Min Long; Fang Lin; Jun-Xia Wei; Ji-Hong Ren; Lin Yan; Ting He; Yuan Han; Hui-Zhong Zhang
Journal:  Med Oncol       Date:  2010-05-11       Impact factor: 3.064

2.  Impairment of breast cancer cell invasion by COX-2-specific inhibitor NS398: roles of CXCR4 and of uPA system.

Authors:  Henriqueta Coimbra Silva; Vera Alves; Luis Alcides Mesquita Nogueira; Manuel Santos Rosa; Lina Carvalho; Fernando Regateiro
Journal:  Med Oncol       Date:  2011-06-03       Impact factor: 3.064

3.  A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells.

Authors:  Hiroshi Yagi; Wenfu Tan; Patricia Dillenburg-Pilla; Sylvain Armando; Panomwat Amornphimoltham; May Simaan; Roberto Weigert; Alfredo A Molinolo; Michel Bouvier; J Silvio Gutkind
Journal:  Sci Signal       Date:  2011-09-20       Impact factor: 8.192

4.  The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis.

Authors:  Jieer Ying; Qi Xu; Gu Zhang; Bixia Liu; Liming Zhu
Journal:  Med Oncol       Date:  2011-06-01       Impact factor: 3.064

Review 5.  Prostaglandins and cancer.

Authors:  D Wang; R N Dubois
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

Review 6.  Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.

Authors:  Won-Tak Choi; Yilei Yang; Yan Xu; Jing An
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

7.  The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma.

Authors:  Brigitte Strahm; Adam D Durbin; Elizabeth Sexsmith; David Malkin
Journal:  Clin Exp Metastasis       Date:  2007-09-01       Impact factor: 5.150

8.  Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications.

Authors:  N Cabioglu; A A Sahin; P Morandi; F Meric-Bernstam; R Islam; H Y Lin; C D Bucana; A M Gonzalez-Angulo; G N Hortobagyi; M Cristofanilli
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

9.  The CXCL12/CXCR4 autocrine loop increases the metastatic potential of non-small cell lung cancer in vitro.

Authors:  Xiaofeng Dai; Zhifu Mao; Jie Huang; Songping Xie; Hao Zhang
Journal:  Oncol Lett       Date:  2012-10-10       Impact factor: 2.967

10.  Practical method for radioactivity distribution analysis in small-animal PET cancer studies.

Authors:  Nikolai V Slavine; Peter P Antich
Journal:  Appl Radiat Isot       Date:  2008-06-14       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.